Prof. Amitis Ramezani | Vaccination | Best Researcher Award

Prof. Amitis Ramezani | Vaccination | Best Researcher Award

 Pasteur Institute of Iran, Iran

Professor Amitis Ramezani is a distinguished figure in infectious diseases with a strong emphasis on Vaccination. Her dedication to public health has shaped vaccination research, vaccination awareness, vaccination policy, and vaccination delivery. Known for her vaccination expertise, she has led vaccination programs, vaccination evaluations, and vaccination safety studies. Her contributions to vaccination epidemiology, vaccination outcomes, and vaccination trials are notable. Ramezani's influence in vaccination communication, vaccination surveillance, and vaccination education is profound. With a career rooted in vaccination, she continues to advance vaccination innovation, vaccination strategy, and vaccination outreach. Her scholarly work enriches vaccination literature, promotes vaccination efficiency, and addresses vaccination concerns. Professor Ramezani is a leading voice in the global vaccination dialogue.

Professional Profile 

ORCID 

Education  

Professor Amitis Ramezani pursued her education  with a strong focus on Vaccination. From her MD to specialization in infectious diseases, she integrated vaccination theories, vaccination modules, and vaccination science into her academic training. At Tehran University, vaccination epidemiology and vaccination safety guided her studies. Her MPH training emphasized vaccination impact, vaccination ethics, and vaccination outreach. Throughout her education, vaccination preparedness, vaccination risk analysis, and vaccination immunity were recurring themes. Her research projects included vaccination trials, vaccination reporting, and vaccination modeling. She aligned her educational goals with global vaccination standards, focusing on vaccination optimization and vaccination sustainability. Ramezani’s academic background underscores her lifetime commitment to advancing the field of Vaccination.

Experience

Amitis Ramezani’s professional trajectory is defined by her leadership in Vaccination. She has led vaccination projects, vaccination coordination teams, and vaccination safety initiatives. At the Pasteur Institute of Iran, she supervised vaccination surveillance, vaccination data analysis, and vaccination policy reviews. Ramezani’s committee roles focused on vaccination monitoring, vaccination risk-benefit evaluations, and vaccination adverse effect investigations. With responsibilities across vaccination implementation, vaccination campaign assessments, and vaccination coverage studies, she shaped national strategies. She contributed to vaccination rollout planning, vaccination incident reporting, and vaccination equity. Her service includes oversight of vaccination trials and fostering multidisciplinary collaboration to ensure Vaccination remains a public health priority.

Research Interest

Vaccination stands at the center of Professor Ramezani’s research interests. Her work includes vaccination immunity, vaccination side effect monitoring, and vaccination coverage evaluation. Ramezani investigates vaccination technology transfer, vaccination in vulnerable populations, and long-term vaccination effects. Her ongoing studies address vaccination resistance, vaccination schedule optimization, and post-vaccination syndromes. She examines vaccination immunogenicity, vaccination antibodies, and vaccination challenges in chronic diseases. Her findings enhance vaccination policy, vaccination preparedness, and vaccination education. With over 30 vaccination-related projects, her efforts push boundaries in vaccination efficiency, vaccination innovation, and vaccination standardization. Her scientific inquiry consistently enhances the field of Vaccination through rigorous investigation and analysis.

Awards and Honors

Professor Ramezani has received recognition for her lifelong dedication to Vaccination. Her accolades highlight excellence in vaccination research, vaccination education, and vaccination innovation. She has been honored for her role in vaccination trial success, vaccination equity initiatives, and vaccination health promotion. Acknowledged by international bodies, her awards reflect achievements in vaccination safety, vaccination monitoring, and vaccination access. She earned distinctions in vaccination campaign leadership, vaccination community engagement, and vaccination protocol development. Her service in vaccination committees, vaccination panels, and vaccination outreach has further solidified her status. Every award she receives reinforces her unwavering impact in the sphere of Vaccination.

Research Skills

Ramezani demonstrates vast research skills centered on Vaccination. She excels in vaccination study design, vaccination cohort analysis, and vaccination efficacy trials. Her skills include managing vaccination databases, conducting vaccination serology, and performing vaccination immunogenicity profiling. She’s adept in vaccination protocol development, vaccination modeling, and vaccination bioinformatics. She leads vaccination monitoring programs, vaccination adverse event reviews, and post-vaccination surveys. Her techniques span vaccination safety evaluation, vaccination trial logistics, and vaccination effectiveness measurement. She continually hones her expertise in vaccination study metrics, vaccination case follow-up, and vaccination field implementation. Her methodological strength ensures high standards in every Vaccination research initiative she leads.

Publications

Title: Nasopharyngeal Carriage, Serotype Distribution, and Antimicrobial Susceptibility of Streptococcus pneumoniae Among PCV13-Vaccinated and -Unvaccinated Children in Iran
Authors: Fatemeh Ashrafian; Mona Sadat Larijani; Saiedeh Haji Maghsoudi; Delaram Doroud; Alireza Fahimzad; Zahra Pournasiri; Elham Jafari; Masoumeh Parzadeh; Sara Abdollahi; Elham Haj Agha Gholizadeh Khiavi et al.
Journal: Vaccines

Title: Circulatory microRNAs as potential biomarkers for different aspects of COVID-19
Authors: Mahsan Zali; Mona Sadat Larijani; Anahita Bavand; Ladan Moradi; Fatemeh Ashrafian; Amitis Ramezani
Journal: Archives of Virology

Title: Manifestations, complications, and treatment of neurobrucellosis: a systematic review and meta-analysis
Authors: Amin Tajerian; Masoomeh Sofian; Nader Zarinfar; Amitis Ramezani
Journal: International Journal of Neuroscience

Title: Long-term rheumatoid manifestations as a consequence of COVID-19 and/or vaccination: A case report after a 2-year follow-up
Authors: Mona Sadat Larijani; Mohammad Banifazl; Afsaneh Karami; Amitis Ramezani
Journal: Heliyon

Title: The impact of ABO blood types on humoral immunity responses and antibody persistency after different COVID‐19 vaccine regimens
Authors: Mona Sadat Larijani; Amir Javadi; Seyed Ebrahim Eskandari; Delaram Doroud; Fatemeh Ashrafian; Mohammad Banifazl; Ali Khamesipour; Anahita Bavand; Amitis Ramezani
Journal: Journal of Medical Virology

Title: Assessment of COVID‐19 Vaccine Impact on Women’s Menstrual Health within an 18‐Month Follow‐Up
Authors: Mona Sadat Larijani; Sana Eybpoosh; Delaram Doroud; Anahita Bavand; Ladan Moradi; Fatemeh Ashrafian; Parinaz Tajmehrabi Namini; Mahsan Zali; Amitis Ramezani; Süleyman Cemil Oğlak
Journal: Obstetrics and Gynecology International

Conclusion

Professor Amitis Ramezani’s career is a testament to dedication in the field of Vaccination. Her impact spans vaccination science, vaccination policy, and vaccination practice. Through her work, vaccination protocols have evolved, vaccination confidence has increased, and vaccination access has improved. She continues to influence vaccination research, vaccination policymaking, and vaccination capacity building. Her legacy is reflected in vaccination awareness, vaccination inclusivity, and vaccination development. She stands as a global advocate for Vaccination, promoting rigorous standards in vaccination trial ethics, vaccination education, and vaccination implementation. Professor Ramezani exemplifies commitment, innovation, and leadership—anchored firmly in the science and service of Vaccination.

Expedito Luna – Infectious Diseases Vaccines – Best Researcher Award

Expedito Luna - Infectious Diseases Vaccines - Best Researcher Award

USP - Brazil

AUTHOR PROFILE

ORCID

EARLY ACADEMIC ROOTS 🌱

Dr. Expedito J.A. Luna's foundational journey in medicine began with a Medical Degree (M.D.) from the Universidade Federal de Pernambuco in 1981, followed by a Medical Residency in Preventive Medicine at the Universidade de São Paulo. His academic path was further enriched with a Master's in Public Health from Universidade Estadual de Campinas and a Ph.D. in Preventive Medicine/Epidemiology from the University of São Paulo. From the start, his scholarly interest gravitated toward epidemiology and public health, especially in the control and surveillance of communicable diseases. These formative years laid the groundwork for his lifelong dedication to combating health crises in Brazil and beyond. Driven by a commitment to vulnerable populations and the scientific potential of Immunoprevention, he was particularly focused on how evidence-based strategies, like Infectious Diseases Vaccines, could curb epidemics and improve public health outcomes. This academic preparation would later empower him to take on high-level responsibilities in both government and academia, ultimately leading to impactful leadership roles. His passion for rigorous training and empirical analysis equipped him to become a recognized authority in the field. Thus, Dr. Luna’s early academic pursuits served as the launchpad for a distinguished career focused on public health innovation and Infectious Diseases Vaccines.

EARLY ACADEMIC ROOTS 🌱

Dr. Expedito J.A. Luna's foundational journey in medicine began with a Medical Degree (M.D.) from the Universidade Federal de Pernambuco in 1981, followed by a Medical Residency in Preventive Medicine at the Universidade de São Paulo. His academic path was further enriched with a Master's in Public Health from Universidade Estadual de Campinas and a Ph.D. in Preventive Medicine/Epidemiology from the University of São Paulo. From the start, his scholarly interest gravitated toward epidemiology and public health, especially in the control and surveillance of communicable diseases. These formative years laid the groundwork for his lifelong dedication to combating health crises in Brazil and beyond. Driven by a commitment to vulnerable populations and the scientific potential of Immunoprevention, he was particularly focused on how evidence-based strategies, like Infectious Diseases Vaccines, could curb epidemics and improve public health outcomes. This academic preparation would later empower him to take on high-level responsibilities in both government and academia, ultimately leading to impactful leadership roles. His passion for rigorous training and empirical analysis equipped him to become a recognized authority in the field. Thus, Dr. Luna’s early academic pursuits served as the launchpad for a distinguished career focused on public health innovation and Infectious Diseases Vaccines.

PROFESSIONAL ENDEAVORS 🏥

Dr. Expedito J.A. Luna’s professional trajectory is marked by decades of service in Brazil’s public health system. He began his work at the State of São Paulo Health Secretariat and later served at the Municipal Health Secretariat. His career then advanced to the national level, where he became Director of the Department of Surveillance and Control of Communicable Diseases at the Ministry of Health. In these roles, he was instrumental in implementing large-scale epidemiological programs targeting vaccine-preventable illnesses and neglected tropical diseases. He brought a scientific mindset and operational discipline to the management of epidemics, working to integrate surveillance, diagnostics, and vaccine strategies. His efforts had a measurable impact on national health metrics, especially in reducing the burden of diseases through expanded immunization campaigns. He also served as a scientific advisor to national STI and AIDS programs, showing the breadth of his public health influence. These professional chapters reflect his commitment to translating data into action and policy. Throughout his career, he has emphasized the importance of scientific evidence in health decision-making, especially around Infectious Diseases Vaccines, which he consistently promoted as a cornerstone of disease prevention and control strategies across Brazil’s healthcare infrastructure.

RESEARCH EXCELLENCE & FOCUS 🔬

A cornerstone of Dr. Luna’s legacy is his prolific research in epidemiology, with a particular focus on vaccine effectiveness and disease surveillance. His academic base at the Institute for Tropical Medicine at the University of São Paulo has been a launchpad for numerous groundbreaking studies. From COVID-19 and dengue to influenza and Zika, he has led or participated in over 30 funded research projects. His investigations often center on the real-world effectiveness of Infectious Diseases Vaccines, including CORONAVAC, influenza, rotavirus, yellow fever, and tetravalent dengue vaccines. He has received grants from esteemed institutions such as FAPESP, CNPq, the Ministry of Health, and international organizations like the Mérieux Foundation and Sanofi. Many of his studies use test-negative case-control designs or cohort approaches to measure vaccine performance in diverse populations, including healthcare workers, pregnant women, and indigenous communities. His work bridges field epidemiology with laboratory science, often addressing disease prevalence, transmission dynamics, and immunological response. Dr. Luna’s research not only advances academic knowledge but also informs national immunization policies. With hundreds of peer-reviewed publications, his data-driven insights have reinforced the critical role of Infectious Diseases Vaccines in managing Brazil’s—and the region’s—public health challenges.

POLICY INFLUENCE & LEADERSHIP 📊

Dr. Luna has played a pivotal role in shaping Brazil’s public health policy, particularly in infectious disease control and immunization programs. His tenure as Director of the Department of Surveillance and Control of Communicable Diseases at the Ministry of Health was marked by significant advancements in national disease prevention strategies. He oversaw large-scale surveillance systems and contributed to the development and evaluation of national vaccine policies, ensuring their alignment with scientific findings. His leadership was vital in coordinating efforts to contain outbreaks of dengue, influenza, Zika, and other emerging threats. He also contributed to global discussions on vaccine strategy and safety, as seen in his co-authorship of influential papers on post-licensure vaccine evaluation. His guidance extended to the National Vaccine Coverage Survey and maternal vaccination initiatives, which were instrumental in protecting vulnerable groups. Dr. Luna's ability to bridge academia and policy-making set a gold standard for evidence-based governance. His focus on Infectious Diseases Vaccines positioned him as a trusted voice in both domestic and international forums. Through his leadership, Brazil has seen greater coherence between scientific discovery and public health application, enhancing the reach and effectiveness of vaccination as a tool for disease control.

TEACHING & MENTORSHIP 📚

Beyond his public health and research contributions, Dr. Luna has nurtured the next generation of epidemiologists as a professor at the University of São Paulo’s Institute for Tropical Medicine. Since 2008, he has played an integral role in training medical students, public health professionals, and postgraduate scholars in infectious disease epidemiology. His courses emphasize critical thinking, data interpretation, and the application of epidemiological methods to real-world problems. He brings field experience into the classroom, enriching academic learning with practical insights. Dr. Luna also mentors young researchers through thesis supervision and research collaboration, many of whom now hold influential positions in public health across Brazil. He is renowned for promoting interdisciplinary learning, encouraging students to explore links between clinical outcomes, environmental factors, and population health. Central to his pedagogy is the pivotal role of Infectious Diseases Vaccines in disease prevention. His mentorship approach is not only academic but also aspirational, instilling a sense of duty and purpose among his mentees. Through his teaching, Dr. Luna ensures that the values of scientific rigor, public health advocacy, and vaccine equity continue to influence Brazil’s healthcare landscape for years to come.

RECOGNITION & ACCOLADES 🏆

Throughout his distinguished career, Dr. Expedito J.A. Luna has earned widespread recognition for his contributions to public health and epidemiology. His efforts have been celebrated not just within Brazil but also in international forums, owing to his collaborative work with organizations like the World Health Organization, Pan American Health Organization, and various global health research foundations. His publications in high-impact journals, ranging from The Lancet to Vaccine and BMJ Open, underscore the scholarly depth and policy relevance of his work. As a principal investigator on critical national studies, including those assessing vaccine coverage, effectiveness, and disease prevalence, Dr. Luna has received prestigious research grants and institutional support across decades. His influence has been instrumental in developing and evaluating policies that continue to shape national immunization strategies. Among his most valuable recognitions is the trust placed in him by Brazil’s Ministry of Health to direct nationwide programs during times of crisis. Across all honors, one theme remains consistent: his unwavering commitment to advancing Infectious Diseases Vaccines as a primary defense against public health threats. Dr. Luna’s accolades are a testament to his lasting impact on science, policy, and population health.

IMPACT & GLOBAL COLLABORATION 🌎

Dr. Luna’s work transcends borders, exemplifying the global nature of public health. Through cross-national research collaborations and policy consulting, he has contributed to a broader understanding of how infectious diseases emerge, spread, and can be controlled through vaccination. His involvement in studies on dengue, influenza, and COVID-19 has provided comparative insights applicable across Latin America and beyond. He has co-authored international papers addressing vaccine strategies, transmission models, and post-licensure evaluations. Dr. Luna’s voice is regularly sought in global forums focused on Infectious Diseases Vaccines, where he shares Brazil’s experiences and learns from global peers. His collaboration with organizations like WHO and PAHO has influenced vaccine rollout strategies and disease surveillance models. He also contributes to international training programs, strengthening capacity in low-resource settings. By advocating for equitable vaccine access and evidence-based interventions, Dr. Luna has helped shape a more unified and proactive global public health response. His legacy extends to influencing vaccine policies not only in Brazil but in other countries that have modeled their strategies after his data-driven approaches. Through this global footprint, he reinforces the indispensable role of Infectious Diseases Vaccines in achieving worldwide health security.

LEGACY & FUTURE VISION 🔮

As Dr. Luna continues his work at the University of São Paulo, his vision for the future remains grounded in scientific advancement and public health equity. He envisions a world where data-driven policies, robust surveillance, and universal access to effective vaccines are the norm rather than the exception. His ongoing projects focus on vaccine effectiveness, particularly for COVID-19 and dengue, reaffirming his belief in the central role of Infectious Diseases Vaccines in combating evolving health threats. He remains deeply involved in guiding young scientists and contributing to research that influences national immunization programs. Looking ahead, he advocates for stronger integration of epidemiological data with digital health tools to improve outbreak detection and response. His legacy lies not only in the programs he helped build or the research he led but also in the public health mindset he helped instill in Brazil and beyond. By continuing to engage with policy-makers, research bodies, and students, Dr. Luna ensures that the next generation will carry forward the torch of scientific integrity and vaccine-driven disease control. His work serves as a blueprint for future epidemiologists seeking to leverage Infectious Diseases Vaccines for a healthier, more resilient world.

NOTABLE PUBLICATION 

  • Title: A spatial case-control study on symptomatic and inapparent primary dengue infections in an endemic city in Brazil
    Authors: Gerusa Figueiredo, Francisco Chiaravalloti, Sérgio Campos, Alessandra Cristina Guedes Pellini, Alvina Clara Felix, Expedito Luna
    Journal: Revista do Instituto de Medicina Tropical de São Paulo
    Year: 2024

 

  • Title: Detection of Internal Transcribed Spacer 1 and hsp70 Genetic Markers Using Restriction Fragment Length Polymorphisms and Sequencing in Identification of Leishmania Species Causing Tegumentary Leishmaniasis in Brazil
    Authors: J.A. Delprete, L.V. de Almeida, A.M. Barros, R.D.C. Soler, A.A. Bittencourt, E.J. de Albuquerque Luna, J.A.L. Lindoso, L.M.A. Braz
    Journal: American Journal of Tropical Medicine and Hygiene
    Year: 2024

 

  • Title: Dynamics of communication on measles vaccination on digital platforms in the Brazilian context: challenges and perspectives
    Authors: Maria da Penha Soares Silva, Vera Lúcia Gattás, Expedito José de Albuquerque Luna
    Journal: Revista do Instituto de Medicina Tropical de São Paulo
    Year: 2024

 

  • Title: Low vaccine coverage and varicella outbreaks in Brazil − 2019–2022
    Authors: D.M. Fujita, L.H. da Silva Nali, R.R. da Costa, H.F. de Andrade Júnior, E.J. de Albuquerque Luna
    Journal: Vaccine
    Year: 2024

 

  • Title: Phylogenetics, Epidemiology and Temporal Patterns of Dengue Virus in Araraquara, São Paulo State
    Authors: C.S. de Souza, G.S. Caleiro, I.M. Claro, J.G. de Jesus, T.M. Coletti, C.A.M. da Silva, Â.A. Costa, M. Inenami, A.C. Ribeiro, A.C. Felix et al.
    Journal: Viruses
    Year: 2024